Literature DB >> 20093357

Atrap deficiency increases arterial blood pressure and plasma volume.

Mona Oppermann1, Bernhard Gess, Frank Schweda, Hayo Castrop.   

Abstract

The angiotensin receptor-associated protein (Atrap) interacts with angiotensin II (AngII) type 1 (AT1) receptors and facilitates their internalization in vitro, but little is known about the function of Atrap in vivo. Here, we detected Atrap expression in several organs of wild-type mice; the highest expression was in the kidney where it localized to the proximal tubule, particularly the brush border. There was no Atrap expression in the renal vasculature or juxtaglomerular cells. We generated Atrap-deficient (Atrap-/-) mice, which were viable and seemed grossly normal. Mean systolic BP was significantly higher in Atrap-/- mice compared with wild-type mice. Dose-response relationships of arterial BP after acute AngII infusion were similar in both genotypes. Plasma volume was significantly higher and plasma renin concentration was markedly lower in Atrap-/- mice compared with wild-type mice. (125)I-AngII binding showed enhanced surface expression of AT1 receptors in the renal cortex of Atrap-/- mice, accompanied by increased carboanhydrase-sensitive proximal tubular function. In summary, Atrap-/- mice have increased arterial pressure and plasma volume. Atrap seems to modulate volume status by acting as a negative regulator of AT1 receptors in the renal tubules.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093357      PMCID: PMC2831856          DOI: 10.1681/ASN.2009060658

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  36 in total

1.  Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention.

Authors:  Hui Zhang; Aihua Zhang; Donald E Kohan; Raoul D Nelson; Frank J Gonzalez; Tianxin Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-14       Impact factor: 11.205

2.  Attenuation of inflammatory vascular remodeling by angiotensin II type 1 receptor-associated protein.

Authors:  Akira Oshita; Masaru Iwai; Rui Chen; Ayumi Ide; Midori Okumura; Shiori Fukunaga; Toyofumi Yoshii; Masaki Mogi; Jitsuo Higaki; Masatsugu Horiuchi
Journal:  Hypertension       Date:  2006-08-21       Impact factor: 10.190

3.  Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney.

Authors:  N Miyata; F Park; X F Li; A W Cowley
Journal:  Am J Physiol       Date:  1999-09

4.  Contribution of the basolateral isoform of the Na-K-2Cl- cotransporter (NKCC1/BSC2) to renin secretion.

Authors:  Hayo Castrop; John N Lorenz; Pernille B Hansen; Ulla Friis; Diane Mizel; Mona Oppermann; Boye L Jensen; Josie Briggs; Ole Skøtt; Jurgen Schnermann
Journal:  Am J Physiol Renal Physiol       Date:  2005-08-16

5.  Novel regulatory effect of angiotensin II type 1 receptor-interacting molecule on vascular smooth muscle cells.

Authors:  Koichi Azuma; Kouichi Tamura; Atsu-ichiro Shigenaga; Hiromichi Wakui; Shin-ichiro Masuda; Yuko Tsurumi-Ikeya; Yutaka Tanaka; Masashi Sakai; Miyuki Matsuda; Tatsuo Hashimoto; Tomoaki Ishigami; Marco Lopez-Ilasaca; Satoshi Umemura
Journal:  Hypertension       Date:  2007-09-17       Impact factor: 10.190

6.  The novel angiotensin II type 1 receptor (AT1R)-associated protein ATRAP downregulates AT1R and ameliorates cardiomyocyte hypertrophy.

Authors:  Yutaka Tanaka; Kouichi Tamura; Yuichi Koide; Masashi Sakai; Yuko Tsurumi; Yoshihiro Noda; Masanari Umemura; Tomoaki Ishigami; Kazuaki Uchino; Kazuo Kimura; Masatsugu Horiuchi; Satoshi Umemura
Journal:  FEBS Lett       Date:  2005-03-14       Impact factor: 4.124

7.  The trafficking protein GABARAP binds to and enhances plasma membrane expression and function of the angiotensin II type 1 receptor.

Authors:  Julia L Cook; Richard N Re; Dawn L deHaro; Jennifer M Abadie; Michelle Peters; Jawed Alam
Journal:  Circ Res       Date:  2008-05-22       Impact factor: 17.367

8.  Interacting molecule of AT1 receptor, ATRAP, is colocalized with AT1 receptor in the mouse renal tubules.

Authors:  Y Tsurumi; K Tamura; Y Tanaka; Y Koide; M Sakai; M Yabana; Y Noda; T Hashimoto; M Kihara; N Hirawa; Y Toya; Y Kiuchi; M Iwai; M Horiuchi; S Umemura
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

9.  Inhibitory effect of angiotensin II type 1 receptor-associated protein on vascular smooth muscle cell growth and neointimal formation.

Authors:  Zhen Li; Zhong-Gao Wang; Xiu Chen; Xiao-Dong Chen
Journal:  Chin Med Sci J       Date:  2007-03

10.  Arterial remodeling and plasma volume expansion in caveolin-1-deficient mice.

Authors:  Sebastian Albinsson; Yulia Shakirova; Anna Rippe; Maria Baumgarten; Bert-Inge Rosengren; Catarina Rippe; Rupert Hallmann; Per Hellstrand; Bengt Rippe; Karl Swärd
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-07-11       Impact factor: 3.619

View more
  13 in total

Review 1.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 2.  Angiotensin receptor-associated proteins: local modulators of the renin-angiotensin system.

Authors:  Hayo Castrop
Journal:  Pflugers Arch       Date:  2012-05-16       Impact factor: 3.657

Review 3.  Angiotensin II and vascular injury.

Authors:  Augusto C Montezano; Aurelie Nguyen Dinh Cat; Francisco J Rios; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2014-06       Impact factor: 5.369

4.  Renal histopathological findings in relation to ambulatory blood pressure in chronic kidney disease patients.

Authors:  Kotaro Haruhara; Nobuo Tsuboi; Kentaro Koike; Akira Fukui; Yoichi Miyazaki; Tetsuya Kawamura; Makoto Ogura; Takashi Yokoo
Journal:  Hypertens Res       Date:  2014-09-18       Impact factor: 3.872

5.  Angiotensin II type 1 receptor-associated protein is an endogenous inhibitor of angiotensin II type 1 receptor action in cardiac hypertrophy: role in check and balance.

Authors:  Zhiping Zhang; Victor J Dzau
Journal:  Hypertension       Date:  2010-03-15       Impact factor: 10.190

6.  Glomerular filtration rate determinations in conscious type II diabetic mice.

Authors:  Benjamin J Bivona; Sungmi Park; Lisa M Harrison-Bernard
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-08

Review 7.  ATRAP, a receptor-interacting modulator of kidney physiology, as a novel player in blood pressure and beyond.

Authors:  Kouichi Tamura; Kengo Azushima; Sho Kinguchi; Hiromichi Wakui; Takahiro Yamaji
Journal:  Hypertens Res       Date:  2021-10-12       Impact factor: 3.872

8.  Integrative genomic analysis of blood pressure and related phenotypes in rats.

Authors:  Fumihiko Takeuchi; Yi-Qiang Liang; Masato Isono; Michiko Tajima; Zong Hu Cui; Yoko Iizuka; Takanari Gotoda; Toru Nabika; Norihiro Kato
Journal:  Dis Model Mech       Date:  2021-05-19       Impact factor: 5.758

9.  Identifying multiple causative genes at a single GWAS locus.

Authors:  Michael J Flister; Shirng-Wern Tsaih; Caitlin C O'Meara; Bradley Endres; Matthew J Hoffman; Aron M Geurts; Melinda R Dwinell; Jozef Lazar; Howard J Jacob; Carol Moreno
Journal:  Genome Res       Date:  2013-09-04       Impact factor: 9.043

10.  Angiotensin-2-mediated Ca2+ signaling in the retinal pigment epithelium: role of angiotensin-receptor-associated-protein and TRPV2 channel.

Authors:  Rene Barro-Soria; Julia Stindl; Claudia Müller; Renate Foeckler; Vladimir Todorov; Hayo Castrop; Olaf Strauß
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.